Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Qubis Limited investment portfolio
Qubis Limited has made numerous investments in companies such as Signacor Therapeutics, Rapid-Myco Technologies, and Antennaware within the Biotech sector.
unknown
Portfolio
12
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (12)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Amply Discovery Limited AMPLY Discovery is a UK biotechnology company that combines artificial‑intelligence engines with synthetic‑biology wet‑lab validation to discover novel therapeutics from the largely untapped non‑coding portion of the genome, targeting high‑impact diseases such as cancer and antimicrobial‑resistant infections. Its integrated platform links computational target identification, molecule design and experimental testing to deliver first‑in‑class drug candidates for pharmaceutical partners. | Healthcare & Life Sciences | Belfast | Confirmed | 2026-03-06 |
| Analytics Engines Limited Analytics Engines Limited delivers data‑science and artificial‑intelligence consulting, providing data‑engineering solutions and AI‑strategy development for organisations. It also participates in EU Horizon 2020 research projects, collaborating with public‑sector bodies and academic partners across Europe. | Software & IT | Belfast | Confirmed | 2025-10-23 |
Shareholding changes (3)
Qubis Limited's positions across portfolio companies2026
- PREFERRED ORDINARY 0 → 141,744
- ORDINARY A 0 → 125,000
Articles (1)
- Signacor Therapeutics secures £1.1m for heart disease treatment development12 May 2026Signacor Therapeutics